E-DRUG: Promoting the contribution of CBOs towards access to ARVS(2)
--------------------------------------------
As someone who has had some experience in rational/quality use, registration
and ADR monitoring of medicines, I have a slight problem in the whole idea
of involving CBOs in access to ARVs, unless it clearly defined.
There is no doubt people in resource poor countries in Africa need access to
ARVs. Why can we not talk about the strengthening of ACCESS TO ESSENTIAL
DRUGS PROGRAMMES? Concentration on ARVs will lead to the creation on two
tiers in the drug supply system and I do not think that is what we, in
Africa, should promote.
Norman Z. Nyazema
Professor
Pharmacology
University of the North
P.Bag X1106
SOVENGA 0727
South Africa
nznyazema@yahoo.com
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug